Guillaume Clavé

Guillaume Clavé

Auto-generated profile, based on publicly available information

Guillaume Clavé

Institut des Biomolécules Max Mousseron, Université de Montpellier, CNRS, ENSCM, 1919 route de Mende, 34095 Montpellier, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
AGAlexandre de Saint Germain
Alexandre de Saint Germain
GCGuillaume Clavé
Guillaume Clavé
MBMarie-Ange Badet-Denisot
Marie-Ange Badet-Denisot
JPJean-Paul Pillot
Jean-Paul Pillot
DCDavid Cornu
David Cornu
FBFrançois-Didier Boyer
François-Didier Boyer
Analysis of the hydrolysis kinetics of strigolactone receptors using enzyme-activated fluorescent probes revealed that the catalytic triad histidine of the receptor forms a covalent interaction with the strigolactone hydrolysis product, the D ring. Strigolactone plant hormones control plant architecture and are key players in both symbiotic and parasitic interactions. They contain an ABC tricyclic lactone connected to a butenolide group, the D ring. The DWARF14 (D14) strigolactone receptor belongs to the superfamily of α/β-hydrolases, and is known to hydrolyze the bond between the ABC lactone and the D ring. Here we characterized the binding and catalytic functions of RAMOSUS3 (RMS3), the pea (Pisum sativum) ortholog of rice (Oryza sativa) D14 strigolactone receptor. Using new profluorescent probes with strigolactone-like bioactivity, we found that RMS3 acts as a single-turnover enzyme that explains its apparent low enzymatic rate. We demonstrated the formation of a covalent RMS3-D-ring complex, essential for bioactivity, in which the D ring was attached to histidine 247 of the catalytic triad. These results reveal an undescribed mechanism of plant hormone reception in which the receptor performs an irreversible enzymatic reaction to generate its own ligand.

16 January 2009 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
CPConstantinos Pantos
Constantinos Pantos
IMIordanis Mourouzis
Iordanis Mourouzis
TSTheodosios Saranteas
Theodosios Saranteas
GCGuillaume Clavé
Guillaume Clavé
HLHeidi Ligeret
Heidi Ligeret
DCDennis V. Cokkinos
Dennis V. Cokkinos

1 April 2014 in Molecular Plant
Verified
Journal Article
Closed access
FBFrançois-Didier Boyer
François-Didier Boyer
AGAlexandre de Saint Germain
Alexandre de Saint Germain
JPJean-Bernard Pouvreau
Jean-Bernard Pouvreau
GCGuillaume Clavé
Guillaume Clavé
JPJean-Paul Pillot
Jean-Paul Pillot
CRCatherine Rameau
Catherine Rameau
Strigolactones (SLs) are known not only as plant hormones, but also as rhizosphere signals for establishing symbiotic and parasitic interactions. The design of new specific SL analogs is a challenging goal in understanding the basic plant biology and is also useful to control plant architectures without favoring the development of parasitic plants. Two different molecules (23 (3'-methyl-GR24), 31 (thia-3'-methyl-debranone-like molecule)) already described, and a new one (AR36), for which the synthesis is presented, are biologically compared with the well-known GR24 and the recently identified CISA-1. These different structures emphasize the wide range of parts attached to the D-ring for the bioactivity as a plant hormone. These new compounds possess a common dimethylbutenolide motif but their structure varies in the ABC part of the molecules: 23 has the same ABC part as GR24, while 31 and AR36 carry, respectively, an aromatic ring and an acyclic carbon chain. Detailed information is given for the bioactivity of such derivatives in strigolactone synthesis or in perception mutant plants (pea rms1 and rms4, Arabidopsis max2 and, max4) for different hormonal functions along with their action in the rhizosphere on arbuscular mycorrhizal hyphal growth and parasitic weed germination.

21 June 2007 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
CBCédric Bouteiller
Cédric Bouteiller
GCGuillaume Clavé
Guillaume Clavé
ABAude Bernardin
Aude Bernardin
BCBertrand Chipon
Bertrand Chipon
MMMarc Massonneau
Marc Massonneau
ARAnthony Romieu
Anthony Romieu

8 December 2020 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
GCGuillaume Clavé
Guillaume Clavé
MRMaeva Reverte
Maeva Reverte
JVJean Jacques Vasseur
Jean Jacques Vasseur
Michael SmietanaMichael Smietana
Michael Smietana
In the past few years, several drugs derived from nucleic acids have been approved for commercialization and many more are in clinical trials. The sensitivity of these molecules to nuclease digestion in vivo implies the need to exploit resistant non-natural nucleotides. Among all the possible modifications, the one concerning the internucleoside linkage is of particular interest. Indeed minor changes to the natural phosphodiester may result in major modifications of the physico-chemical properties of nucleic acids. As this linkage is a key element of nucleic acids’ chemical structures, its alteration can strongly modulate the plasma stability, binding properties, solubility, cell penetration and ultimately biological activity of nucleic acids. Over the past few decades, many research groups have provided knowledge about non-natural internucleoside linkage properties and participated in building biologically active nucleic acid derivatives. The recent renewing interest in nucleic acids as drugs, demonstrated by the emergence of new antisense, siRNA, aptamer and cyclic dinucleotide molecules, justifies the review of all these studies in order to provide new perspectives in this field. Thus, in this review we aim at providing the reader insights into modified internucleoside linkages that have been described over the years whose impact on annealing properties and resistance to nucleases have been evaluated in order to assess their potential for biological applications. The syntheses of modified nucleotides as well as the protocols developed for their incorporation within oligonucleotides are described. Given the intended biological applications, the modifications described in the literature that have not been tested for their resistance to nucleases are not reported.

12 July 2011 in Chemical Science
Verified
Journal Article
Closed access
PDF file
GCGuillaume Clavé
Guillaume Clavé
SCStéphane Campidelli
Stéphane Campidelli
Amongst the different classes of nanomaterials, carbon nanotubes (CNTs) are extremely promising for applications in electronics, solar energy conversion, materials science and medicinal chemistry. However in order to use them for those applications an accurate control of the functionalisation of the nanotubes is required. Many reactions can be performed on the π-conjugated framework of CNTs (i.e. cycloadditions, radical additions or halogenations). These reactions, although very efficient, require, in general, experimental conditions which are weakly compatible with sensitive organic or biological compounds. The emergence of new or re-actualised synthetic methods (known under the term of “click chemistry”) has the potential to provide an elegant protocol to prepare carbon nanotube-based functional materials. This review will gather the recent results described in the literature using “click chemistry” to functionalise carbon nanotubes.